Type 2 diabetes and obesity are intimately linked; reduction of bodyweight improves glycemic control, mortality and morbidity. Treating obesity in the diabetic is hampered as some diabetic ...

The proposed mechanism by which the fluoroquinolones induce glycemic abnormalities is not clearly understood. Reports of fluoroquinolone-induced hypoglycemia are abundant, but reports of ...